Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: goldenrodger who wrote (1817)	1/15/2008 4:49:30 PM
From: tuck	Read Replies (2) \| Respond to of 1826

>>Since MOGN gapped up about $60 on the 10th of Dec, it's price and volume have remained flat. The gorilla says its going to $63 intermediate.<< What drugs are you on? Eisai is taking MOGN out for $41 cash. It's never hit $60, and is not likely to do so unless another offer comes in out of the blue. I'd say that's pretty unlikely. And you're also hallucinating about talking guerillas? Better call 911 for yourself, pronto! Cheers, Tuck